Cargando…
Disseminated necrotizing leukoencephalopathy eight months after alemtuzumab treatment for multiple sclerosis
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977646/ https://www.ncbi.nlm.nih.gov/pubmed/27503238 http://dx.doi.org/10.1186/s40478-016-0352-1 |
| _version_ | 1782447068011298816 |
|---|---|
| author | Metz, Imke Rieckmann, Peter Kallmann, Boris-Alexander Brück, Wolfgang |
| author_facet | Metz, Imke Rieckmann, Peter Kallmann, Boris-Alexander Brück, Wolfgang |
| author_sort | Metz, Imke |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4977646 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-49776462016-08-10 Disseminated necrotizing leukoencephalopathy eight months after alemtuzumab treatment for multiple sclerosis Metz, Imke Rieckmann, Peter Kallmann, Boris-Alexander Brück, Wolfgang Acta Neuropathol Commun Letter to the Editor BioMed Central 2016-08-08 /pmc/articles/PMC4977646/ /pubmed/27503238 http://dx.doi.org/10.1186/s40478-016-0352-1 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Letter to the Editor Metz, Imke Rieckmann, Peter Kallmann, Boris-Alexander Brück, Wolfgang Disseminated necrotizing leukoencephalopathy eight months after alemtuzumab treatment for multiple sclerosis |
| title | Disseminated necrotizing leukoencephalopathy eight months after alemtuzumab treatment for multiple sclerosis |
| title_full | Disseminated necrotizing leukoencephalopathy eight months after alemtuzumab treatment for multiple sclerosis |
| title_fullStr | Disseminated necrotizing leukoencephalopathy eight months after alemtuzumab treatment for multiple sclerosis |
| title_full_unstemmed | Disseminated necrotizing leukoencephalopathy eight months after alemtuzumab treatment for multiple sclerosis |
| title_short | Disseminated necrotizing leukoencephalopathy eight months after alemtuzumab treatment for multiple sclerosis |
| title_sort | disseminated necrotizing leukoencephalopathy eight months after alemtuzumab treatment for multiple sclerosis |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977646/ https://www.ncbi.nlm.nih.gov/pubmed/27503238 http://dx.doi.org/10.1186/s40478-016-0352-1 |
| work_keys_str_mv | AT metzimke disseminatednecrotizingleukoencephalopathyeightmonthsafteralemtuzumabtreatmentformultiplesclerosis AT rieckmannpeter disseminatednecrotizingleukoencephalopathyeightmonthsafteralemtuzumabtreatmentformultiplesclerosis AT kallmannborisalexander disseminatednecrotizingleukoencephalopathyeightmonthsafteralemtuzumabtreatmentformultiplesclerosis AT bruckwolfgang disseminatednecrotizingleukoencephalopathyeightmonthsafteralemtuzumabtreatmentformultiplesclerosis |